Effect of Ashwagandha in treatment of Alzheimer
Phase 3
Recruiting
- Conditions
- Alzheimer's disease.Alzheimer disease, unspecifiedG30.9
- Registration Number
- IRCT20220514054845N1
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Having informed consent for study participation
Having a CDR score less than or equal to 2
Having an ADAS-COG score higher than or equal to 12
Ability to participate in the study
Exclusion Criteria
Inability to participate in the study
Inability to continue treatment
Presence of heart disease
Substance abuse and alcohol addiction
Taking anticoagulant drugs
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method